Podcast
MSL Talk: Tom Caravela, Conor McGladrigan, Kevin Peterson
Objection Handling for Field Medical Professionals
Summary
In this episode, Linda Traylor joins Tom Caravela to delve into the art of objection handling for MSLs. They explore the nuances between MSLs and sales teams, introducing a structured approach known as the 5 e's framework. Emphasizing the significance of pre-call planning, the discussion highlights common pitfalls and strategies to prepare for frequent objections. The conversation underscores the value of team practice and the influence of MSL opinions, while stressing mentorship and collaboration. The episode wraps up with a teaser for an upcoming book review on negotiation tactics, inviting listeners to engage and apply these insights.
My guest today is Linda Traylor, Sr Principal Medical Affairs at IQVIA and we discuss objection handling for MSLs and field medical professionals.
Linda shares…
👉 How objection handling for MSLs is different than objection handling for sales reps
👉 The framework MSLs should use for objection handling
👉 What mistakes MSLs make in handling objections
👉 If MSLs should address and handle every objection
👉 The importance of preparation and pre-call planning
👉 Typical examples of objections from KOLs
MSL objection handling, 5 e's framework, medical science liaisons, pre-call planning, negotiation tactics
Related Topics
You May Also Like
MSL Talk: Tom Caravela, Conor McGladrigan, Kevin Peterson
Podcast
MSL Talk: Tom Caravela
How to Start Presenting Like a Pro
Article
Kushal T. Kadakia, MSc, Malke Asaad, MD, Erica Adlakha, MS, Michael J. Overman, MD, Cristina M. Checka, MD, and Anaeze C. Offodile II, MD, MPH
Virtual Clinical Trials in Oncology-Overview, Challenges, Policy Considerations, and Future Directions
Article
Emmanuelle Jacqueta, Ghania Kerouani-Lafayeb, Francoise Grudeb, Sergio Goncalvesb, Annie Lorenced, Florence Turcryb, Liora Brunelb, Laetitia Belgodereb, Adrien Monardc, Gaëlle Guyaderb, Lotfi Boudalib, Nicolas Albin
Comparative study on anticancer drug access times between FDA, EMA and the French temporary authorisation for use program over 13 years
Article
Aaron S. Long, BS; Audrey D. Zhang, MD; Caitlin E. Meyer, MLIS; Alexander C. Egilman, BS; Joseph S. Ross, MD, MHS; Joshua D. Wallach, PhD, MS
Evaluation of Trials Comparing Single-Enantiomer Drugs to Their Racemic Precursors: A Systematic Review
Article
iNIZIO